3-43691006-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016006.6(ABHD5):āc.14A>Cā(p.Glu5Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000274 in 1,566,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_016006.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABHD5 | NM_016006.6 | c.14A>C | p.Glu5Ala | missense_variant | 1/7 | ENST00000644371.2 | NP_057090.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABHD5 | ENST00000644371.2 | c.14A>C | p.Glu5Ala | missense_variant | 1/7 | NM_016006.6 | ENSP00000495778 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000803 AC: 16AN: 199244Hom.: 0 AF XY: 0.0000809 AC XY: 9AN XY: 111210
GnomAD4 exome AF: 0.0000275 AC: 39AN: 1416796Hom.: 0 Cov.: 30 AF XY: 0.0000340 AC XY: 24AN XY: 704918
GnomAD4 genome AF: 0.0000266 AC: 4AN: 150166Hom.: 0 Cov.: 32 AF XY: 0.0000410 AC XY: 3AN XY: 73192
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 02, 2023 | The c.14A>C (p.E5A) alteration is located in exon 1 (coding exon 1) of the ABHD5 gene. This alteration results from a A to C substitution at nucleotide position 14, causing the glutamic acid (E) at amino acid position 5 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 31, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 5 of the ABHD5 protein (p.Glu5Ala). This variant is present in population databases (rs757473420, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with ABHD5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1425120). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at